questionText: To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS officials and pharmaceutical companies on making Enhertu available on the NHS for patients with HER2-low metastatic breast cancer.
answerText: Ministers met with the manufacturers of Enhertu, AstraZeneca, and Daiichi Sankyo, in November 2024 to encourage them to engage constructively with NHS England and the National Institute for Health and Care Excellence (NICE) to reach a commercial agreement...
heading: Trastuzumab Deruxtecan